Prestige Consumer Healthcare Inc.

NYSE:PBH Rapporto sulle azioni

Cap. di mercato: US$4.4b

Prestige Consumer Healthcare Gestione

Gestione criteri di controllo 4/4

Prestige Consumer Healthcare Il CEO è Ron Lombardi, nominato in Jun2015, e ha un mandato di 9.92 anni. la retribuzione annua totale è $ 5.76M, composta da 17.4% di stipendio e 82.6% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.65% delle azioni della società, per un valore di $ 28.43M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 8.5 anni e 5 anni.

Informazioni chiave

Ron Lombardi

Amministratore delegato

US$5.8m

Compenso totale

Percentuale dello stipendio del CEO17.40%
Mandato del CEO9.9yrs
Proprietà del CEO0.6%
Durata media del management8.5yrs
Durata media del Consiglio di amministrazione5yrs

Aggiornamenti recenti sulla gestione

Recent updates

These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well

May 09
These 4 Measures Indicate That Prestige Consumer Healthcare (NYSE:PBH) Is Using Debt Reasonably Well

Prestige Consumer Healthcare Inc. (NYSE:PBH) Investors Are Less Pessimistic Than Expected

Apr 16
Prestige Consumer Healthcare Inc. (NYSE:PBH) Investors Are Less Pessimistic Than Expected

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 70% Above Its Share Price

Mar 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 70% Above Its Share Price

Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 09
Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Feb 07
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now

Jan 16
Pinning Down Prestige Consumer Healthcare Inc.'s (NYSE:PBH) P/S Is Difficult Right Now

Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

Dec 04
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Could Be 45% Below Their Intrinsic Value Estimate

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Nov 03
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing

Sep 10
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Popularity With Investors Is Under Threat From Overpricing
author-image

Brand Building And Innovations Propel Long-Term Growth Amid Supply Chain Challenges

Investments in brand building and marketing for key products like Hydralyte and Summer's Eve are enhancing consumer awareness and driving revenue growth.

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Jul 16
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

May 22
Revenues Not Telling The Story For Prestige Consumer Healthcare Inc. (NYSE:PBH)

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 26
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Mar 05
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 50% Undervalued

Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Feb 11
Prestige Consumer Healthcare Inc. (NYSE:PBH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Feb 05
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Shares May Have Run Too Fast Too Soon

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Dec 14
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Sep 10
Prestige Consumer Healthcare (NYSE:PBH) Seems To Use Debt Quite Sensibly

Prestige Consumer Healthcare: Unproductive Buyback And Excessive Valuation

Aug 15

Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

Jun 12
Is Prestige Consumer Healthcare (NYSE:PBH) Using Too Much Debt?

An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

May 20
An Intrinsic Calculation For Prestige Consumer Healthcare Inc. (NYSE:PBH) Suggests It's 43% Undervalued

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Mar 17
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Has Caught The Eye Of Investors

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Mar 02
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Feb 08
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Intrinsic Value Is Potentially 75% Above Its Share Price

Prestige Consumer Healthcare reports Q3 earnings beat; updates FY23 guidance

Feb 02

Prestige Consumer Healthcare: Taking My Winnings Off The Table

Jan 19

Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Nov 23
Here's Why Prestige Consumer Healthcare (NYSE:PBH) Can Manage Its Debt Responsibly

Prestige Consumer Healthcare GAAP EPS of $1.02 beats by $0.02, revenue of $289.3M beats by $6.07M

Nov 03

Holding Prestige Consumer Healthcare

Aug 31

If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

Aug 26
If EPS Growth Is Important To You, Prestige Consumer Healthcare (NYSE:PBH) Presents An Opportunity

We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Aug 05
We Think Prestige Consumer Healthcare (NYSE:PBH) Can Stay On Top Of Its Debt

Prestige Consumer Healthcare GAAP EPS of $1.09 beats by $0.05, revenue of $277.1M beats by $8.18M

Aug 04

Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

May 27
Should You Be Adding Prestige Consumer Healthcare (NYSE:PBH) To Your Watchlist Today?

Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

May 05
Is Prestige Consumer Healthcare (NYSE:PBH) A Risky Investment?

Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Feb 22
Does Prestige Consumer Healthcare (NYSE:PBH) Deserve A Spot On Your Watchlist?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ron Lombardi rispetto agli utili di Prestige Consumer Healthcare?
DataCompenso totaleStipendioGuadagni aziendali
Mar 31 2025n/an/a

US$215m

Dec 31 2024n/an/a

US$214m

Sep 30 2024n/an/a

US$206m

Jun 30 2024n/an/a

US$205m

Mar 31 2024US$6mUS$1m

US$209m

Dec 31 2023n/an/a

-US$81m

Sep 30 2023n/an/a

-US$82m

Jun 30 2023n/an/a

-US$84m

Mar 31 2023US$6mUS$1m

-US$82m

Dec 31 2022n/an/a

US$210m

Sep 30 2022n/an/a

US$209m

Jun 30 2022n/an/a

US$203m

Mar 31 2022US$6mUS$937k

US$205m

Dec 31 2021n/an/a

US$189m

Sep 30 2021n/an/a

US$179m

Jun 30 2021n/an/a

US$179m

Mar 31 2021US$5mUS$888k

US$165m

Dec 31 2020n/an/a

US$166m

Sep 30 2020n/an/a

US$163m

Jun 30 2020n/an/a

US$152m

Mar 31 2020US$5mUS$875k

US$142m

Dec 31 2019n/an/a

-US$34m

Sep 30 2019n/an/a

-US$34m

Jun 30 2019n/an/a

-US$36m

Mar 31 2019US$4mUS$850k

-US$36m

Compensazione vs Mercato: La retribuzione totale di Ron ($USD 5.76M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 7.42M ).

Compensazione vs guadagni: La retribuzione di Ron è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Ron Lombardi (60 yo)

9.9yrs
Mandato
US$5,763,133
Compensazione

Mr. Ronald M. Lombardi, also known as Ron, served as a Director at Consumer Healthcare Products Association. He has been the Chief Executive Officer and President of Prestige Brands Holdings, Inc. (now Pre...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Ronald Lombardi
Chairman9.9yrsUS$5.76m0.65%
$ 28.4m
Christine Sacco
CFO & COO8.7yrsUS$2.00m0.047%
$ 2.1m
William P'Pool
Senior VP8.5yrsUS$1.34m0.032%
$ 1.4m
Adel Mekhail
Executive Vice President of Marketing & Sales6yrsUS$1.32m0.031%
$ 1.3m
Jeffrey Zerillo
Senior Vice President of Operationsno dataUS$862.93k0.079%
$ 3.5m
Philip Terpolilli
Director of Investor Relationsno dataNessun datoNessun dato
Dean Siegal
Director of Communicationsno dataNessun datoNessun dato
Mary Fritz
Senior Vice President of Quality & Regulatory Affairs6.9yrsNessun dato0.030%
$ 1.3m
8.5yrs
Durata media
60yo
Età media

Gestione esperta: Il team dirigenziale di PBH è esperto e expertise (durata media dell'incarico 8.5 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Ronald Lombardi
Chairman9.9yrsUS$5.76m0.65%
$ 28.4m
John Byom
Lead Independent Director19.3yrsUS$273.33k0.097%
$ 4.3m
Clesteen Clark
Independent Director4.3yrsUS$257.08k0.014%
$ 617.1k
Dawn Zier
Independent Director5yrsUS$260.63k0.020%
$ 884.3k
Sheila Hopkins
Independent Director9.8yrsUS$243.33k0.048%
$ 2.1m
James D'Arecca
Independent Director1.8yrsUS$197.92kNessun dato
John Kelly
Independent Director1yrNessun datoNessun dato
5.0yrs
Durata media
63yo
Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PBH sono considerati esperti (durata media dell'incarico 5 anni).

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2025/05/20 22:05
Prezzo dell'azione a fine giornata2025/05/20 00:00
Guadagni2025/03/31
Guadagni annuali2025/03/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Prestige Consumer Healthcare Inc. è coperta da 16 analisti. 7 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Olivia Tong CheangBofA Global Research
Linda Bolton-WeiserB. Riley Securities, Inc.
Susan AndersonCanaccord Genuity